These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1356671)

  • 41. Correction of serum neuroleptic activity for blood-to-brain distribution: a method that may render radioreceptor assay results comparable between neuroleptics.
    Young AS; Faraone SV; Brown WA
    J Clin Psychopharmacol; 1989 Oct; 9(5):361-3. PubMed ID: 2571620
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blonanserin, a novel antipsychotic, is suitable for treating schizophrenia associated with hyperprolactinemia: a case series.
    Kawabe K; Horiuchi F; Ueno S
    Clin Neuropharmacol; 2013; 36(6):239-41. PubMed ID: 24201238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naïve schizophrenic patients.
    Sawamura K; Suzuki Y; Fukui N; Sugai T; Someya T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1511-4. PubMed ID: 16824658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Risperidone and Aripiprazole on Serum Levels of Prolactin, Testosterone and Estradiol in Female Patients with Schizophrenia.
    Jiang XJ; Wu FX; Zhang JP; Shi L; Hu JQ; Zhu HZ; Xiao B; Lin WC; Wen YG; Shang DW
    Drug Res (Stuttg); 2018 Jul; 68(7):410-414. PubMed ID: 29482256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
    Busch DA; Fang VS; Meltzer HY
    Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A; Segal S; Yeret A; Ben-David M
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract]   [Full Text] [Related]  

  • 49. Sexual dysfunction and hyperprolactinemia in schizophrenia before and after six weeks of D
    Düring SW; Nielsen MØ; Bak N; Glenthøj BY; Ebdrup BH
    Psychiatry Res; 2019 Apr; 274():58-65. PubMed ID: 30780063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia.
    Magharious W; Goff DC; Amico E
    Psychiatry Res; 1998 Feb; 77(3):159-66. PubMed ID: 9707298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma prolactin concentration and psychopathology of schizophrenia.
    Otani K; Kondo T; Ishida M; Tanaka O; Yasui N; Suzuki A; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Nov; 20(8):1369-74. PubMed ID: 9004343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteopenia associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics.
    Liu-Seifert H; Kinon BJ; Ahl J; Lamberson S
    Ann N Y Acad Sci; 2004 Dec; 1032():297-8. PubMed ID: 15677434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between major Multidrug Resistance 1 (MDR1) gene polymorphisms and plasma concentration of prolactin during risperidone treatment in schizophrenic patients.
    Yasui-Furukori N; Tsuchimine S; Saito M; Nakagami T; Sato Y; Kaneko S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1230-4. PubMed ID: 17559997
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serum prolactin levels in chronic schizophrenics].
    Ravalli S; Barone R; Molinaro G; Leone NB
    Minerva Psichiatr; 1987; 28(1):31-4. PubMed ID: 2888003
    [No Abstract]   [Full Text] [Related]  

  • 55. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment.
    Wik G; Wiesel FA; Eneroth P; Sedvall G; Aström G
    Acta Psychiatr Scand; 1986 Aug; 74(2):161-7. PubMed ID: 2877544
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Effect of Antipsychotics on Bone Mineral Density and Sex Hormones in Male Patients with Schizophrenia.
    Bulut SD; Bulut S; Atalan DG; Tulaci RG; Türker T; Gürçay E; Aydemir Ç
    Psychiatr Danub; 2016 Sep; 28(3):255-262. PubMed ID: 27658834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
    Mielke DH; Gallant DM; Kessler C
    Am J Psychiatry; 1977 Dec; 134(12):1371-5. PubMed ID: 21571
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation between prolactin response and therapeutic effects of zotepine in schizophrenic patients.
    Otani K; Kondo T; Kaneko S; Ishida M; Fukushima Y
    Int Clin Psychopharmacol; 1994; 9(4):287-9. PubMed ID: 7868851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failure of pyridoxine to effect neuroleptic-induced hyperprolactinemia in psychotic patients.
    Brambilla F; Penati G; Freni S; Bottinelli S; Maffei C; Maiella V
    J Endocrinol Invest; 1979; 2(3):299-302. PubMed ID: 43342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    Braddock LE; Blake IM
    Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.